Zofran, which could be more commonly known by its generic name ondansetron, may potentially cause birth defects in babies when their mothers are on the prescription drug during pregnancy. GlaxoSmithKline, the pharmaceutical company from London, England that manufactures Zofran, insists that their drug does not pose an immediate threat to unborn children. Those who have taken Zofran while pregnant are telling a different story.
A couple from Illinois filed a lawsuit indicating that while the woman was pregnant with their child, she was prescribed Zofran by her doctor as a way to treat nausea and morning sickness symptoms. She claims that the makers of Zofran did not provide any label or indication that would suggest birth defects could be a possible side effect of taking this medication. She believes that if GlaxoSmithKline provided a warning label or any general knowledge that this could transpire, then her son may not have been born with a heart defect that will impact his entire life. Her son had been born with Tetralogy of Fallot, a congenital heart defect that causes oxygen in the blood to reach poor levels—a complication that requires immediate heart surgery at the time of detection and further surgeries in the future. This young boy, who is about nine years old now, suffers from a condition that deeply affects all aspects of his life. The defect puts him at a greater risk for infection, and there’s a possibility that the tissue lining of his ventricular septal could detach and block his arteries. If this were to happen at any point in the future, he would need to be rushed to the hospital within an hour or he could die from this occurrence. All of these issues stemming from the mere fact that his mother received a prescription for medication she should have never been allowed to take in the first place. Continue reading